Novavax | NVAX - Кредиторская задолженность





Кредиторская задолженность Изменить Дата
Adma Biologics USD 22.52M 1.5M 2025-12
Agenus USD 82.99M 2.3M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Cassava Sciences USD 41.65M 4.44M 2025-12
Geron USD 11.26M 146K 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
MannKind USD 9.03M 1.76M 2025-12
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 317M 50M 2025-12
Novartis USD 4.46B 99M 2025-12
Novavax USD 24.58M 9.35M 2025-12
Pfizer USD 5.02B 142M 2025-09
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09